Log In
Print this Print this

Almerol, alendronate (MER 103)

  Manage Alerts
Collapse Summary General Information
Company Merrion Pharmaceuticals plc
DescriptionOral formulation of alendronate sodium delivered using Gastrointestinal Permeation Enhancement Technology (GIPET) platform
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationOsteoporosis
Indication DetailsTreat and prevent osteoporosis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today